tiprankstipranks
Advertisement
Advertisement

TEM Stock Latest News

Tempus AI added to CellCarta’s CDx commercialization lab network
The FlyTempus AI added to CellCarta’s CDx commercialization lab network
9d ago
TEM
Personalis says not providing guidance or conducting earnings call
PremiumThe Fly
Personalis says not providing guidance or conducting earnings call
10d ago
TEM
PSNL
Tempus AI announces study results of PRISM2
PremiumThe Fly
Tempus AI announces study results of PRISM2
11d ago
TEM
MSFT
Tempus AI price target lowered to $56 from $58 at Piper Sandler
PremiumThe Fly
Tempus AI price target lowered to $56 from $58 at Piper Sandler
11d ago
TEM
Tempus AI price target lowered to $70 from $80 at BTIG
PremiumThe Fly
Tempus AI price target lowered to $70 from $80 at BTIG
11d ago
TEM
Tempus AI price target lowered to $56 from $64 at H.C. Wainwright
PremiumThe FlyTempus AI price target lowered to $56 from $64 at H.C. Wainwright
12d ago
TEM
Tempus AI: Buy Rating Reiterated as Outperformance Continues and $80 Price Target Remains Unchanged
Premium
Ratings
Tempus AI: Buy Rating Reiterated as Outperformance Continues and $80 Price Target Remains Unchanged
12d ago
TEM
Tempus AI price target lowered to $52 from $64 at BofA
Premium
The Fly
Tempus AI price target lowered to $52 from $64 at BofA
12d ago
TEM
Tempus AI price target lowered to $50 from $60 at Stifel
PremiumThe Fly
Tempus AI price target lowered to $50 from $60 at Stifel
12d ago
TEM
Tempus AI–Personalis Deal: Integration Risks, Rising Costs, and Regulatory Scrutiny Could Undermine Synergy Gains
PremiumCompany Announcements
Tempus AI–Personalis Deal: Integration Risks, Rising Costs, and Regulatory Scrutiny Could Undermine Synergy Gains
14d ago
TEM
Tempus AI price target lowered to $59 from $67 at Baird
PremiumThe Fly
Tempus AI price target lowered to $59 from $67 at Baird
15d ago
TEM
Tempus AI: Solid Execution and Raised Sales Outlook Offset by Execution Risks, Supporting Hold Rating
PremiumRatings
Tempus AI: Solid Execution and Raised Sales Outlook Offset by Execution Risks, Supporting Hold Rating
15d ago
TEM
Tempus AI: Strong Q2 Results, Locked-In Growth Through 2027 Support Unchanged $75 Price Target and Buy Rating
PremiumRatingsTempus AI: Strong Q2 Results, Locked-In Growth Through 2027 Support Unchanged $75 Price Target and Buy Rating
15d ago
TEM
Tempus AI Posts Strong Q2 Results, Raises 2026 Outlook
Premium
Company Announcements
Tempus AI Posts Strong Q2 Results, Raises 2026 Outlook
15d ago
8K
TEM
Tempus AI raises FY26 revenue view to $1.595B-$1.605B, consensus $1.59B
Premium
The Fly
Tempus AI raises FY26 revenue view to $1.595B-$1.605B, consensus $1.59B
15d ago
TEM
Tempus AI reports Q2 adjusted EPS (4c), consensus (15c)
PremiumThe Fly
Tempus AI reports Q2 adjusted EPS (4c), consensus (15c)
15d ago
TEM
tempus AI Inc Class A options imply 6.9% move in share price post-earnings
PremiumThe Fly
tempus AI Inc Class A options imply 6.9% move in share price post-earnings
15d ago
TEM
Tempus AI announces national launch of OneOme pharmacogenomics testing
PremiumThe Fly
Tempus AI announces national launch of OneOme pharmacogenomics testing
24d ago
TEM
Tempus AI: Buy Rating Reaffirmed as Personalis Deal Strengthens MRD Position; $75 Price Target Maintained
PremiumRatings
Tempus AI: Buy Rating Reaffirmed as Personalis Deal Strengthens MRD Position; $75 Price Target Maintained
24d ago
TEM
Personalis price target raised to $16.25 from $11 at BTIG
PremiumThe FlyPersonalis price target raised to $16.25 from $11 at BTIG
25d ago
TEM
PSNL
Tempus AI Announces Merger Agreement to Acquire Personalis
Premium
Company Announcements
Tempus AI Announces Merger Agreement to Acquire Personalis
25d ago
8K
TEM
Tempus AI (TEM) Drops on $1.7B Personalis Deal; Needham Analyst Calls the Slide a “Market Misread”
Premium
Market News
Tempus AI (TEM) Drops on $1.7B Personalis Deal; Needham Analyst Calls the Slide a “Market Misread”
25d ago
TEM
PSNL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >